Bio-Connect
ICC/IF analysis of PFA-fixed HeLa cells (4h of LPS treatment) using GTX02535 Histone H3K9K14K23K27ac (Acetyl Lys9/Lys14/Lys23/Lys27) antibody. Red : Primary antibody Green : Tubulin Blue : DAPI Permeabilization : 0.1% Triton X-100 Dilution : 1:200
ICC/IF analysis of PFA-fixed HeLa cells (4h of LPS treatment) using GTX02535 Histone H3K9K14K23K27ac (Acetyl Lys9/Lys14/Lys23/Lys27) antibody. Red : Primary antibody Green : Tubulin Blue : DAPI Permeabilization : 0.1% Triton X-100 Dilution : 1:200
ICC/IF analysis of PFA-fixed HeLa cells (4h of LPS treatment) using GTX02535 Histone H3K9K14K23K27ac (Acetyl Lys9/Lys14/Lys23/Lys27) antibody. Red : Primary antibody Green : Tubulin Blue : DAPI Permeabilization : 0.1% Triton X-100 Dilution : 1:200

Histone H3K9K14K23K27ac (Acetyl Lys9/Lys14/Lys23/Lys27) antibody

GTX02535
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Histone H3K9K14K23K27ac (Acetyl Lys9/Lys14/Lys23/Lys27) antibody - Orthogonal Validated
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:2000. ICC/IF: 1:100-1:500. IHC-P: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes. Huang SH et al., 2022 Jan 21, Int J Mol Sci
    Read more